secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001437749-26-004800
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech raises ~$8.3M via warrant exercise inducement; issues new Series H warrants for 6.4M shares
--------------------------------------------------------------------------------

- Holders exercise 2,122,652 existing warrants at $3.90 per share; gross proceeds ~$8.3M.
- Company issues new Series H warrants for up to 6,367,956 shares (300% of exercised) with 5-year term.
- New warrant exercise price = lesser of $3.90 or lowest VWAP in 5 trading days post-announcement; floor $0.962.
- Shareholder approval required for issuance of new warrant shares; resale registration to be filed by March 31, 2026.
- Roth Capital served as financial advisor, receiving 7% of gross proceeds from the warrant exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926004800/0001437749-26-004800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926004800/mbrx20260219_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-004800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer